tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

NGNE Stock Latest News

Neurogene announces peer-reviewed publication of EXACT transgene technology
The FlyNeurogene announces peer-reviewed publication of EXACT transgene technology
2d ago
NGNE
Biotech stocks slide as Marks resignation seen being negative for sector
PremiumThe Fly
Biotech stocks slide as Marks resignation seen being negative for sector
5d ago
DYN
MGX
BMO says Peter Marks resignation ‘significant negative’ for biotech
PremiumThe Fly
BMO says Peter Marks resignation ‘significant negative’ for biotech
5d ago
MGX
BEAM
Neurogene’s Promising Outlook: Buy Rating Backed by Robust Financials and Upcoming Clinical Milestones
PremiumRatings
Neurogene’s Promising Outlook: Buy Rating Backed by Robust Financials and Upcoming Clinical Milestones
9d ago
NGNE
Neurogene Reports 2024 Financial Results and Advances in Rett Syndrome Trial
PremiumCompany Announcements
Neurogene Reports 2024 Financial Results and Advances in Rett Syndrome Trial
9d ago
NGNE
Neurogene’s Promising Clinical Progress and Financial Stability Earns Buy Rating
PremiumRatingsNeurogene’s Promising Clinical Progress and Financial Stability Earns Buy Rating
10d ago
NGNE
Neurogene files $300M mixed securities shelf
Premium
The Fly
Neurogene files $300M mixed securities shelf
11d ago
NGNE
Neurogene price target lowered to $50 from $55 at H.C. Wainwright
Premium
The Fly
Neurogene price target lowered to $50 from $55 at H.C. Wainwright
11d ago
NGNE
Neurogene price target lowered to $38 from $46 at Baird
PremiumThe Fly
Neurogene price target lowered to $38 from $46 at Baird
11d ago
NGNE
Neurogene Highlights Progress in Rett Syndrome Program
PremiumCompany Announcements
Neurogene Highlights Progress in Rett Syndrome Program
3M ago
8K
NGNE
Neurogene files to sell 4M shares of common stock for holders
PremiumThe Fly
Neurogene files to sell 4M shares of common stock for holders
4M ago
NGNE
3 Stocks to Buy Now, 12/2/2024, According to Corporate Insiders
PremiumMarket News
3 Stocks to Buy Now, 12/2/2024, According to Corporate Insiders
4M ago
META
NGNE
Neurogene Adjusts Clinical Trial After Setback
PremiumCompany AnnouncementsNeurogene Adjusts Clinical Trial After Setback
4M ago
8K
NGNE
Neurogene price target lowered to $45 from $60 at BMO Capital
Premium
The Fly
Neurogene price target lowered to $45 from $60 at BMO Capital
5M ago
NGNE
Neurogene Inc. Faces Uncertainty with NGN-101 Program Amid FDA Challenges and Strategic Hurdles
Premium
Company Announcements
Neurogene Inc. Faces Uncertainty with NGN-101 Program Amid FDA Challenges and Strategic Hurdles
5M ago
NGNE
Neurogene price target lowered to $45 from $60 at BMO Capital
PremiumThe Fly
Neurogene price target lowered to $45 from $60 at BMO Capital
5M ago
NGNE
Neurogene price target lowered to $46 from $72 at Baird
PremiumThe Fly
Neurogene price target lowered to $46 from $72 at Baird
5M ago
NGNE
Neurogene selloff on safety event an overreaction, says H.C. Wainwright
PremiumThe Fly
Neurogene selloff on safety event an overreaction, says H.C. Wainwright
5M ago
NGNE
Closing Bell Movers: Super Micro up 28% on compliance update
PremiumThe Fly
Closing Bell Movers: Super Micro up 28% on compliance update
5M ago
ACM
SYM
Neurogene reports Q3 EPS ($1.19), consensus ($1.22)
PremiumThe FlyNeurogene reports Q3 EPS ($1.19), consensus ($1.22)
5M ago
NGNE
Neurogene Adjusts NGN-401 Trial After Adverse Event
Premium
Company Announcements
Neurogene Adjusts NGN-401 Trial After Adverse Event
5M ago
8K
NGNE
Neurogene provides update on NGN-401 clinical trial for Rett syndrome
Premium
The Fly
Neurogene provides update on NGN-401 clinical trial for Rett syndrome
5M ago
NGNE

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >